Katarzyna Śladowska

Potential use of psilocybin drugs in the treatment of depression

Expert Opinion on Emerging Drugs October 2, 2023 Katarzyna Śladowska, Paweł Kawalec, Tomasz Brzostek et al. 4 citations

Clinical phase I-II trials published to date reported promising results for psilocybin in the treatment of patients with major depressive disorder and treatment-resistant depression, in a relatively short time after administration. However, before psilocybin is approved for use and administered to patients with depression, the results of large ongoing phase III clinical trials are needed to...